EudraCT Number: 2016-004963-38 Sponsor Protocol Number: CABAZ_L_07454 Start Date: 2017-05-03
Sponsor Name: Netherlands Cancer Institute
Full Title: A randomized, open label, Phase IIB trial of Optimal Sequencing of Treatment Options for Poor Risk Metastasized Castration Resistant Prostate Cancer Previously Treated with Docetaxel (OSTRICh trial)
Medical condition: Metastasized Castration Resistant Prostate Cancer
Disease: Version SOC Term Classification Code Term Level
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10036909 Prostate cancer metastatic PT
20.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10060862 Prostate cancer PT
21.0 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10036911 Prostate cancer recurrent PT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10066489 Progression of prostate cancer LLT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10076506 Castration-resistant prostate cancer LLT
21.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10062904 Hormone-refractory prostate cancer PT
Population Age: Adults, Elderly Gender: Male
Trial protocol: NL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2004-000534-36 Sponsor Protocol Number: PR 1903 Start Date: 2004-09-13
Sponsor Name: Laboratoires Expanscience
Full Title: Efficacy and Safety of Piascledine 300 versus Chondroitin Sulfate in a 6 Months Treatment plus 2 Months Observation in Patients with Osteoarthritis of the Knee
Medical condition: Osteoarthritis of the Knee
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SK (Ongoing) HU (Ongoing) CZ (Ongoing)
Trial results: (No results available)
EudraCT Number: 2010-021020-94 Sponsor Protocol Number: ACT11575 Start Date: 2011-03-10
Sponsor Name: Sanofi-aventis Recherche & Développement
Full Title: A randomized, double-blind, parallel-group, placebo- and active calibrator-controlled study assessing the clinical benefit of SAR153191 subcutaneous (SC) on top of methotrexate (MTX) in patients wi...
Medical condition: active rheumatoid arthritis
Disease: Version SOC Term Classification Code Term Level
13.1 10028395 - Musculoskeletal and connective tissue disorders 10039073 Rheumatoid arthritis PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Prematurely Ended) IT (Prematurely Ended) HU (Completed) CZ (Prematurely Ended) ES (Prematurely Ended)
Trial results: View results

EudraCT Number: 2007-000004-33 Sponsor Protocol Number: IPR/18 Start Date: 2008-10-13
Sponsor Name: MOLMED
Full Title: NGR012: A phase II study of NGR-hTNF administered in combination with doxorubicin every 3 weeks in patients affected by advanced or metastatic ovarian cancer
Medical condition: Patients affected by advanced or metastatic ovarian cancer previously treated with platinum regimens (cis or carboplatin) plus paclitaxel
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10057529 Ovarian cancer metastatic PT
Population Age: Adults, Elderly Gender: Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2007-000031-26 Sponsor Protocol Number: R256918DIA2001 Start Date: 2007-12-18
Sponsor Name: Janssen-Cilag International NV
Full Title: A 12-Week, Double-Blind, Randomized, Placebo-Controlled Study in Type 2 Diabetes Mellitus Subjects to Evaluate the Efficacy, Safety and Tolerability of MTP Inhibitor JNJ-16269110
Medical condition: Diabetes
Disease: Version SOC Term Classification Code Term Level
9.1 10018424 Glucose metabolism disorders (incl diabetes mellitus) HLGT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) DE (Completed) FI (Ongoing) NL (Completed) SE (Completed) DK (Completed)
Trial results: View results

EudraCT Number: 2004-001383-46 Sponsor Protocol Number: Sweet 0406 Start Date: 2004-10-25
Sponsor Name: Karolinska University Hospital, Huddinge
Full Title: Swdeish Exelon Titration study
Medical condition: Patients with possible or probable Alzheimer disease (AD)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: (No results available)
EudraCT Number: 2004-000139-27 Sponsor Protocol Number: A509 1018 Start Date: 2004-09-14
Sponsor Name: Pfizer AB
Full Title: A Phase 3, Double-Blind, Placebo-Controlled, Randomized, Parallel Group, Multicenter Study of the Efficacy, Safety, and Tolerability of Fixed Combination Torcetrapib/Atorvastatin Administered Orall...
Medical condition: Mixed dyslipidemia (Frederickson Types IIa and IIb)
Disease: Version SOC Term Classification Code Term Level
10058108
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results

EudraCT Number: 2004-000145-38 Sponsor Protocol Number: C0743T06 Start Date: 2004-11-16
Sponsor Name: Centocor B.V.
Full Title: A Phase 2, Double-blind, Placebo-controlled, Randomized, Dose-ranging Study of Multiple Subcutaneous Injections of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects with Relapsing-remit...
Medical condition: Relapse-remitting Multiple Sclerosis (RRMS)
Disease: Version SOC Term Classification Code Term Level
10048393
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: CZ (Ongoing) HU (Completed) GB (Completed)
Trial results: View results
EudraCT Number: 2004-000148-26 Sponsor Protocol Number: SP516 Start Date: 2004-07-30
Sponsor Name: Schwarz BioSciences Inc.
Full Title: A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease wh...
Medical condition: Parkinson's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) SE (Completed) HU (Completed) ES (Ongoing) CZ (Completed) IT (Completed) AT (Completed)
Trial results: View results

EudraCT Number: 2004-000406-51 Sponsor Protocol Number: EMD20001 Start Date: 2004-09-16
Sponsor Name: GlaxoSmithKline
Full Title: A Prospective, Randomized, Double-blind, Placebo Controlled, Dose Ranging, Multi-Center Study of the Safety and Efficacy of Three Days Continuous Intravenous Infusion of GR270773 in the Treatment o...
Medical condition: Suspected or Confirmed Gram-negative Severe Sepsis in Adults
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) ES (Ongoing) CZ (Completed) LV (Completed) AT (Completed) HU (Completed) DK (Completed)
Trial results: View results